2-Azaniumyl-4-hydroxy-4-oxobutanoate

Details

Top
Internal ID 5baa6380-9ef1-4d68-bd51-dcde49d22ae8
Taxonomy Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Alpha amino acids and derivatives > Aspartic acid and derivatives
IUPAC Name 2-azaniumyl-4-hydroxy-4-oxobutanoate
SMILES (Canonical) C(C(C(=O)[O-])[NH3+])C(=O)O
SMILES (Isomeric) C(C(C(=O)[O-])[NH3+])C(=O)O
InChI InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)
InChI Key CKLJMWTZIZZHCS-UHFFFAOYSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C4H7NO4
Molecular Weight 133.10 g/mol
Exact Mass 133.03750770 g/mol
Topological Polar Surface Area (TPSA) 105.00 Ų
XlogP -3.20
Atomic LogP (AlogP) -3.18
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 3

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 2-Azaniumyl-4-hydroxy-4-oxobutanoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.5576 55.76%
Caco-2 - 0.9637 96.37%
Blood Brain Barrier + 0.5250 52.50%
Human oral bioavailability - 0.5429 54.29%
Subcellular localzation Mitochondria 0.4979 49.79%
OATP2B1 inhibitior - 0.8578 85.78%
OATP1B1 inhibitior + 0.9506 95.06%
OATP1B3 inhibitior + 0.9428 94.28%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.9697 96.97%
P-glycoprotein inhibitior - 0.9874 98.74%
P-glycoprotein substrate - 0.9813 98.13%
CYP3A4 substrate - 0.7568 75.68%
CYP2C9 substrate - 0.6049 60.49%
CYP2D6 substrate - 0.8276 82.76%
CYP3A4 inhibition - 0.9794 97.94%
CYP2C9 inhibition - 0.9550 95.50%
CYP2C19 inhibition - 0.9649 96.49%
CYP2D6 inhibition - 0.9415 94.15%
CYP1A2 inhibition - 0.9462 94.62%
CYP2C8 inhibition - 0.9867 98.67%
CYP inhibitory promiscuity - 0.9951 99.51%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7800 78.00%
Carcinogenicity (trinary) Non-required 0.7615 76.15%
Eye corrosion - 0.9350 93.50%
Eye irritation + 0.6352 63.52%
Skin irritation - 0.7480 74.80%
Skin corrosion - 0.9135 91.35%
Ames mutagenesis - 0.7100 71.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8461 84.61%
Micronuclear + 0.5300 53.00%
Hepatotoxicity + 0.6125 61.25%
skin sensitisation - 0.9650 96.50%
Respiratory toxicity - 0.8222 82.22%
Reproductive toxicity - 0.7667 76.67%
Mitochondrial toxicity - 0.7750 77.50%
Nephrotoxicity - 0.5974 59.74%
Acute Oral Toxicity (c) III 0.7004 70.04%
Estrogen receptor binding - 0.9382 93.82%
Androgen receptor binding - 0.8532 85.32%
Thyroid receptor binding - 0.9198 91.98%
Glucocorticoid receptor binding - 0.8359 83.59%
Aromatase binding - 0.9160 91.60%
PPAR gamma - 0.8249 82.49%
Honey bee toxicity - 0.9259 92.59%
Biodegradation + 0.9250 92.50%
Crustacea aquatic toxicity - 0.8300 83.00%
Fish aquatic toxicity - 0.9038 90.38%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 90.12% 96.09%
CHEMBL2581 P07339 Cathepsin D 85.89% 98.95%
CHEMBL4040 P28482 MAP kinase ERK2 85.40% 83.82%
CHEMBL3060 Q9Y345 Glycine transporter 2 84.91% 99.17%
CHEMBL221 P23219 Cyclooxygenase-1 81.01% 90.17%

Cross-Links

Top
PubChem 57397078
NPASS NPC162282